Venture Capital & Angel Financing

Our attorneys regularly represent venture capital, corporate and angel investors as well as growing companies in a wide range of financing transactions, including:

• Early stage seed rounds
• Convertible debt financing
• Institutional venture rounds
• Syndicated investment special purpose vehicles
• Broker and company sold private placements
• Secondary sales of portfolio companies
• Secondary sales of partnership interest
• Investor representation in connection with disposition or IPO of portfolio companies

Clients include venture capital funds, strategic corporate investors, hedge funds and angel investors, start-up companies and other rapid growth enterprises.

We understand the market within which venture capital transactions operate. We have developed a strong practice by delivering the highest caliber of work while being able to respond to our clients’ need to complete transactions in a timely and cost-effective manner.

Our deep experience with private financing transactions and solid understanding of the venture capital industry has guided our development of a disciplined, process driven approach to venture capital and angel financing transactions. Whether representing an investor or company we:

• Understand that your objective is our success, so we start every engagement with one question—what do you hope to achieve?
• Create a transaction plan, schedule and team to meet your objectives
• Ensure that senior legal leadership is heavily involved in your transaction
• Utilize a disciplined and methodical document drafting, review and negotiation process
• Provide structured due diligence review and disclosure review process

We have closed thousands of private financing transactions with an aggregate value in excess of $2 billion.

Representative Cases

• Over $2 billion in venture financings
• Represented $1 billion plus venture firm in over 200 investments
• Represented Fortune 100 retailer’s corporate venture capital group in numerous venture investments
• Represented Fortune 500 medical device company in numerous venture investments
• Represented numerous venture investors throughout U.S. in seed stage, venture and late stage investments
• Represented investors in secondary acquisition of portfolio securities
• Represented venture investors in over $1 billion in exit transactions

Main Contact

Show all Venture Capital & Angel Financing professionals